Protagonist Therapeutics (PTGX) Current Assets: 2017-2025
Historic Current Assets for Protagonist Therapeutics (PTGX) over the last 9 years, with Sep 2025 value amounting to $586.4 million.
- Protagonist Therapeutics' Current Assets rose 23.00% to $586.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $586.4 million, marking a year-over-year increase of 23.00%. This contributed to the annual value of $591.6 million for FY2024, which is 66.39% up from last year.
- Latest data reveals that Protagonist Therapeutics reported Current Assets of $586.4 million as of Q3 2025, which was down 2.67% from $602.5 million recorded in Q2 2025.
- In the past 5 years, Protagonist Therapeutics' Current Assets ranged from a high of $627.6 million in Q1 2024 and a low of $235.7 million during Q1 2023.
- Its 3-year average for Current Assets is $481.3 million, with a median of $570.9 million in 2024.
- As far as peak fluctuations go, Protagonist Therapeutics' Current Assets tumbled by 30.97% in 2023, and later spiked by 166.21% in 2024.
- Over the past 5 years, Protagonist Therapeutics' Current Assets (Quarterly) stood at $340.7 million in 2021, then decreased by 28.66% to $243.1 million in 2022, then spiked by 46.28% to $355.6 million in 2023, then skyrocketed by 66.39% to $591.6 million in 2024, then increased by 23.00% to $586.4 million in 2025.
- Its last three reported values are $586.4 million in Q3 2025, $602.5 million for Q2 2025, and $605.9 million during Q1 2025.